Sexually transmitted infections greatly increase the risk of HIV infection in pregnancy
New NNRTI doravirine matches efavirenz for first-line HIV treatment
Lopinavir/ritonavir or 3TC PrEP equally protective against infant HIV infection during breastfeeding
Heart attack risk in people with HIV may be falling – but not in women
Nipping HIV in the bud: could we use genotyping to interrupt transmission?
Novel two-drug maintenance combination works at least as well as triple therapy: stage set for long-lasting injectable formulation
Protected T-cells persist and proliferate in HIV gene therapy study
Raltegravir has the edge over two protease inhibitors in three-drug comparison study
The 'Boston patients' experience HIV rebound after stem cell transplants
